-
1 Comment
Gufic Biosciences Limited is currently in a long term uptrend where the price is trading 46.7% above its 200 day moving average.
From a valuation standpoint, the stock is 54.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Gufic Biosciences Limited's total revenue rose by 47.7% to $1B since the same quarter in the previous year.
Its net income has increased by 87.8% to $132M since the same quarter in the previous year.
Finally, its free cash flow grew by 40.1% to $187M since the same quarter in the previous year.
Based on the above factors, Gufic Biosciences Limited gets an overall score of 5/5.
Exchange | NSE |
---|---|
CurrencyCode | INR |
Industry | Drug Manufacturers - Specialty & Generic |
ISIN | INE742B01025 |
Sector | Healthcare |
Market Cap | 36B |
---|---|
PE Ratio | 44.25 |
Target Price | None |
Dividend Yield | 0.0% |
Beta | 0.72 |
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GUFICBIO.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025